Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies MORRISVILLE, N.C., Oct. 7, 2025...
RealTime eClinical Solutions co-authors industry-first guide for sponsor-site collaboration on technology choice. SAN ANTONIO, Oct. 7, 2025 /PRNewswire/ -- When...
FAYETTEVILLE, Ark., Oct. 7, 2025 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with dozens of leading...
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the...
Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer...
Parexel’s Site Alliance Program strengthens global partnerships with clinical research sites and reinforces leadership in site engagement excellenceRALEIGH, N.C., Oct....
-- Integrating a computational workflow that leverages multi-omics data with a proprietary, humanized in vivo screening platform, T-knife identified highly...
Derisq delivers actionable insights about drug safety, efficacy and off-target risks prior to committing development capitalBOSTON, Oct. 07, 2025 (GLOBE...
Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184SOUTH...
SAN CARLOS, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity...
NORCROSS, Ga., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3...
Groundbreaking remotely operable robotic system to transform intervention for stroke and cardiovascular disease, while radically expanding access to care for...
For seven years, a critical application to grow cannabis for FDA approved medicine has languished at the Drug Enforcement Administration...
Clario partners with the University of Oxford's NeuroMetrology Lab to transform Parkinson's disease research with the Opal® wearable sensor system. Partnership...
In this free webinar, learn how Patient Experience Organizations (PXOs) identify and remove experience-level barriers that traditional CROs and agencies...
In this free webinar, hear from CNS thought-leaders on the transformative power of objective measures of brain function in neuropsychiatry clinical...
Unveiled at BioTechX Europe 2025, the new solutions are purpose-built to accelerate research, clinical trial design and regulatory processes. ROCKVILLE,...
Live Demonstrations of AI Site Twin Technology to Highlight How Advanced AI is Transforming Clinical Trial Timelines LAGUNA BEACH, Calif.,...